47 studies found for:    cardiogenic shock
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Danish Cardiogenic Shock Trial
Conditions: Cardiogenic Shock Acute;   Acute Myocardial Infarction
Interventions: Device: Conventional circulatory support;   Device: Impella cVAD
2 Terminated Comparison of Standard Treatment Versus Standard Treatment Plus Extracorporeal Life Support (ECLS) in Myocardial Infarction Complicated With Cardiogenic Shock
Conditions: Myocardial Infarction;   Shock, Cardiogenic
Intervention: Device: Extra-Corporeal Life Support -Impella 2.5
3 Unknown  Intraaortic Balloon Pump in Cardiogenic Shock II
Conditions: Myocardial Infarction;   Shock, Cardiogenic
Intervention: Device: Intraaortic balloon pump
4 Completed Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock
Condition: Shock, Cardiogenic
Intervention: Drug: Abciximab
5 Recruiting Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock
Condition: Cardiogenic Shock
Intervention: Drug: epinephrine/norepinephrine
6 Recruiting CardShock Study and Registry
Condition: Cardiogenic Shock
Intervention:
7 Completed Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation
Conditions: Shock, Cardiogenic;   Heart Failure;   Acute Myocardial Infarction
Intervention: Drug: Pyruvate
8 Completed Aortic Balloon Counterpulastion in Myocardial Infarction Related Shock
Conditions: Myocardial Infarction;   Cardiogenic Shock
Intervention: Device: Intra-aortic balloon pump counterpulsation
9 Terminated A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack
Condition: Shock, Cardiogenic
Intervention: Drug: Tilarginine Acetate Injection intravenous infusion
10 Completed Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)
Conditions: Shock, Cardiogenic;   Myocardial Infarction
Interventions: Device: Left Ventricular Assist Device Impella LP 2.5;   Device: Intraaortic Balloon Pump
11 Unknown  Skeletal Muscle Oxygenation in Critically Ill
Conditions: Heart Failure;   Sepsis;   Septic Shock;   Cardiogenic Shock
Intervention: Device: NiRS measurment of tissue oxygenation
12 Completed Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
Conditions: Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Infarction;   Myocardial Ischemia;   Shock, Cardiogenic
Interventions: Procedure: angioplasty, transluminal, percutaneous coronary;   Procedure: coronary artery bypass;   Drug: thrombolytic therapy
13 Completed Acute Chest Pain Treatment and Evaluation (ACTION) Study
Condition: Chest Pain
Intervention: Procedure: Stress nuclear scan
14 Recruiting Oxidant-antioxidant Activity, Free Radicle Activity, Immune Response and Biomarkers in Extracorporeal Membrane Oxygenation (ECMO) Patients
Conditions: Free Radical Activity;   Oxidation Damage Marker;   Glutathione Peroxidase Activity for Antioxidation;   IL-6, IL-12, TGF-β and Other Biochemical Concentrations;   Immune Cellular Changes
Intervention:
15 Recruiting A Trial of Routine Aspiration Thrombectomy With Percutaneous Coronary Intervention (PCI) Versus PCI Alone in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary PCI
Conditions: Acute Coronary Syndrome;   ST Elevation Myocardial Infarction;   Percutaneous Coronary Intervention
Intervention: Procedure: Percutaneous Coronary Intervention with or without manual aspiration thrombectomy
16 Completed Routine Angioplasty and Stenting After Fibrinolysis for Acute Myocardial Infarction
Condition: Myocardial Infarction
Intervention: Procedure: Routine Early Percutaneous Coronary Intervention after Thrombolysis
17 Unknown  Levosimendan Versus Dobutamine in Shock Patients
Conditions: Cardiogenic Shock;   Septic Shock
Interventions: Drug: Levosimendan;   Drug: Dobutamine
18 Completed HEROIC (Heparin Requirement in Counterpulsation)
Condition: Cardiogenic Shock
Intervention: Drug: Heparin
19 Completed Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.
Conditions: Myocardial Infarction;   Heart Failure;   Cardiogenic Shock
Interventions: Drug: levosimendan;   Drug: placebo,
20 Active, not recruiting The Melatonin Adjunct in the Acute myocaRdial Infarction Treated With Angioplasty
Condition: Acute Myocardial Infarction
Intervention: Drug: melatonin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years